2023 Influenza Vaccine Market Report
Part 1 of 3: The Upcoming Flu Season

The 2022–2023 U.S. flu season peaked earlier than in past years, with confirmed influenza-like illnesses and hospitalizations in October 2022. Over 26 million influenza-like illnesses and 290,000 hospitalizations were reported in the previous flu season. Following the Southern Hemisphere’s lead, the U.S. prepares for a potentially difficult 2023-2024 flu season.
Download the first of three preview reports for early insights into the upcoming flu season, including:
- An estimated 166.5 million flu vaccine doses will be manufactured for the upcoming 2023–2024 flu season.
- Earlier flu vaccination is recommended for children in the U.S. receiving two doses of the influenza vaccine.
- In the 2023-2024 Australia flu season, 80% of those admitted to the hospital with flu-related symptoms have been children.
Free Download For HIDA Members
Download
Don't Miss The Webinar: Preparing For The 2023-2024 Flu Season
Join Dr. Litjen (L.J.) Tan, PhD, Chief Policy and Partnerships Officer of Immunize.org and Co-Chair of the National Adult and Influenza Immunization Summit, to find out how you can help your provider customers protect their patients from the flu. Learn more and register here.